VEA
OYST

Virtus ETF Advisers’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Virtus ETF Advisers’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-14,995
Closed -$274K – 405
2021
Q1 		$274K Buy
14,995
+266
+2% +$5.58K 0.12% 263
2020
Q4 		$277K Buy
14,729
+4,017
+38% +$86.6K 0.12% 259
2020
Q3 		$226K Sell
10,712
-1,476
-12% -$34.5K 0.12% 283
2020
Q2 		$352K Buy
+12,188
New +$367K 0.17% 263

Other funds holding OYST

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
IFA
Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Virtus ETF Advisers's OYST Position: Q2 2021 in Review

Virtus ETF Advisers sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q2 2021, closing a stake of 14,995 shares — an estimated $274K sold.

Virtus ETF Advisers first reported a position in OYST in Q2 2020 and held it in 4 quarters. The position peaked at $352K in Q2 2020. 58 funds tracked by Wall St. Rank hold OYST as of Q2 2021.

  • Virtus ETF Advisers reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Virtus ETF Advisers sold 14,995 Oyster Point Pharma, Inc. Common Stock shares in Q2 2021, an estimated $274K.
  • Virtus ETF Advisers first reported a position in Oyster Point Pharma, Inc. Common Stock in Q2 2020 and held it in 4 quarters.
  • Virtus ETF Advisers's Oyster Point Pharma, Inc. Common Stock position peaked at $352K in Q2 2020.
  • 58 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q2 2021.

Based on Virtus ETF Advisers's 13F filing for Q2 2021, filed 10 Aug 2021.